anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

190,321-190,380 of 319,975

filter-aware
11
The diagram uses a central hub to represent the core experience, surrounded by eight spokes representing specific cultural values, each linked to a descriptive callout.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
12
The map distinguishes between Middletown Valley Bank branches (circles) and Mlend offices (triangles).Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
13
The slide provides a comparative overview of three specific geographic markets, highlighting population, growth, and key employers.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
14
The slide highlights Middletown Valley Bank's position in three different markets (Washington County, MD; Frederick County, MD; Franklin County, PA) using a blue highlight row for the subject company.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
15
The chart visualizes the growth of deposits per branch between 2017 and 2022, with a table providing the raw data.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
16
The slide displays four bar charts with CAGR annotations for each metric.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
17
The slide includes a disclaimer about the data date at the bottom left.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
18
The slide displays trends for Loan Loss Reserve/Gross Loans, Nonperforming Assets, Loan Loss Reserve/NPLs, and Net Charge-Offs/Avg. Loans.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
19
The slide provides a clear breakdown of deposit types, balances, and percentages, along with qualitative commentary on deposit costs and drivers.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
20
The slide provides a granular view of the bank's investment portfolio composition and credit quality commentary.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
21
Includes a footnote regarding bank-level data usage for 2017 and 2018.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
22
LTM data reflects Q2 2022.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
23
Includes footnotes regarding non-GAAP measures and Q2 2022 annualization.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
24
Data points represent annual figures except for YTD 2022.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
25
Includes footnotes regarding tax asset impairment and one-time charges.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
26
The table shows the impact of a new capital raise on shareholders' equity and book value metrics.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
27
The slide demonstrates that the bank maintains capital ratios above regulatory 'well capitalized' standards.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
28
Includes footnotes regarding non-GAAP measures and specific period adjustments.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
29
Community Heritage Financial | IPO Presentation Deck | 38 slidesCommunity Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
30
Community Heritage Financial | IPO Presentation Deck | 38 slidesCommunity Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
31
Data is presented in thousands of dollars ($000s).Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
32
Includes footnotes regarding tax asset impairment and one-time charges.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
33
Includes LTM (Last Twelve Months) column and specific footnotes regarding loan loss provisions.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
34
Includes footnotes regarding specific accounting changes and credit events.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
35
Includes footnotes regarding specific accounting impacts and non-GAAP measures.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
36
The slide presents a company overview and a table of key financial metrics including loan origination volume, fulfillment services, unit counts, and purchase percentage.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
37
The slide presents data for Middletown, Jefferson, Myersville, Boonsboro, Hagerstown, and Waynesboro.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
38
Includes two distinct tables: one for Tangible Common Equity/Assets and one for Adjusted Revenue/Expense/Efficiency Ratio.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
01
Slide 1
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
02
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a structured table-like layout to categorize key business and clinical updates.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
04
The slide uses a timeline-style visualization for clinical trial phases.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
05
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
06
The slide uses a structured table format to summarize key product attributes.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a causal chain/process flow to show how the drug combination interrupts the pathway from stimulus to cancer growth.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a table structure to map clinical strategy to market opportunity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
09
The slide uses a table format to link clinical trial progress with market opportunity (patient numbers) and medical need.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
10
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
11
The slide uses a three-column layout to show the individual strengths of the partners and the synergy of the combined therapy.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide outlines a clinical trial protocol using a sequential phase design.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide features a person sitting on a rock overlooking a landscape, with the company logo on their jacket.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide provides a scientific foundation for the CLDN6xCD3 bispecific antibody program.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide highlights CLDN6 in the context of the CLDN family tree.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a list-based structure to present three key pillars of the target's clinical profile.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The table highlights the prevalence column with an orange box.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide illustrates the modular assembly of a bispecific antibody from two distinct components.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The charts show dose-response curves where the proprietary antibodies (IM301, IM302) maintain high binding to CLDN6 while showing minimal off-target binding compared to the benchmark.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide compares the library against a benchmark (IMAB027) in terms of reactivity and cytotoxicity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide features a person sitting on a mountain peak, which is a common visual metaphor for vision or future outlook.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses a timeline format to track progress of two distinct drug development programs.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
24
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
25
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations 1 hit
01
Slide 1
Exhibit 99.1 indicates this is likely a public filing or investor relations document.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
02
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
03
Slide provides a snapshot of product approval, financial performance, and market opportunity.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SetupLoop · Golden Circle1 hit
04
Includes market sizing data and clinical characteristics of the target patient segment.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectively, creating a market need.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
06
The slide uses a biological pathway diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Includes product packaging imagery and regulatory status summary.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit